Ravindra B. Ghooi, Deepa Divekar | Perspectives in Clinical Research | 5(4) | 2014 | Source NCBI-PMC Abstract Aims and Objectives: Sponsors need to pay for management of all serious adverse events suffered by subjects in a clinical trial and to… Continue reading
Ramesh Shankar | PharmaBiz.com | Mumbai | 10 November 2014 The Union health ministry’s Apex Committee, headed by Union health secretary, has turned down a proposal by the Drugs Controller General of India (DCGI) to dispose of clinical trial proposals… Continue reading
Zachary Brennan | 10 Nov 2014 The Chinese authorities are supplementing their current regulations around clinical trials with new mandates for the hospitals that conduct the studies. Read full article Continue reading
Vijay Ramnath Jayaraman | India Forbes | 2014 Now that the 2014 general elections are in the rear view mirror, Prime Minister Narendra Modi and his ministers face the challenge of expectations set by the media and all his supporters.… Continue reading
Esther Napolitano | Memorial Sloan Kettering Cancer Centre | 20 October 2014 Medical oncologist Paul Sabbatini demystifies common misconceptions surrounding clinical trials. Read full article Continue reading
Melinda Cooper, Katherine Waldby | Duke University Press | 2014 Forms of embodied labor, such as surrogacy and participation in clinical trials, are central to biomedical innovation, but they are rarely considered as labor. Melinda Cooper and Catherine Waldby take… Continue reading
